WHO ICTRP trial
A Phase 2b Study of MK-6024 in Adults with Precirrhotic Nonalcoholic…
CTIS2022-502647-35-00 · EU Clinical Trials Information System · Not Recruiting
Key facts
| Trial ID | CTIS2022-502647-35-00 |
|---|---|
| Public title | A Phase 2b Study of MK-6024 in Adults with Precirrhotic Nonalcoholic Steatohepatitis |
| Scientific title | A Phase 2b Randomized, Double-Blind Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Efinopegdutide (MK-6024) in Adults with Precirrhotic Nonalcoholic Steatohepatitis - MK-6024-013 |
| Primary sponsor | Merck Sharp & Dohme LLC |
| Registry | EU Clinical Trials Information System |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): No Therapeutic exploratory (Phase II): Yes Therapeutic confirmatory - (Phase III): No Therapeutic use - (Phase IV): No |
| Countries | Chile;China;Colombia;Thailand;United States;Canada;Japan;Hong Kong;Turkey;Israel;Korea, Democratic People's Republic of;Switzerland;Peru;South Africa;Puerto Rico;Singapore;Mexico;United… |
| Conditions | Non-alcoholic steatohepatitis MedDRA version: 22.0Level: PTClassification code: 10053219Term: Non-alcoholic steatohepatitis Class: 100000004871;Therapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18] |
| Interventions | Product Name: SEMAGLUTIDE, Product Code:SUB32188, Pharmaceutical Form: SOLUTION FOR INJECTION, Other descriptive name: , Strength: , Product Name: efinopegdutide, Product Code:PRD9386877, Pharmaceutical Form: SOLUTION FOR INJECTION IN… |
| Registration date | Apr 24, 2023 |
| Target size | 316 |
| Secondary IDs | U1111-1285-0933;153067 |
| Registry page | euclinicaltrials.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: